scholarly journals PBI34 Paying for Curative GENE Therapies: Potential, Barriers and Healthcare Reforms for Risk-Sharing between Payers and Industry in a MULTI-Payer Healthcare System

2020 ◽  
Vol 23 ◽  
pp. S416
Author(s):  
N. Ruedemann ◽  
M. Florian ◽  
M.P. Schoenermark
Author(s):  
Izhar Faisal ◽  
Saima Salam ◽  
Manisha Arora

With an ever worsening shortage of healthcare workers, there has been a global shift towards strengthening of interprofessional education (IPE). IPE has existed as a powerful tool in developed countries, but in developing countries like India, it is still in its infancy. Several models of interprofessional education exist, yet India lags behind in implementing these models in academic curricula. Rudimentary curriculum, inefficient healthcare system, and maldistribution of health professionals are some of the potential barriers. A complete overhaul of the healthcare system along with progressive strategies of incorporation of IPE needs to be debated, and associated limitations need to be addressed. Adequate institutional support, well-constructed protocols, infrastructural revamp, and change of workplace culture are vital for IPE to succeed and be sustainable. This chapter provides an overview of IPE and collaborative practice in Indian settings and presents an account of an Indian institution utilizing IPP approach and highlights potential challenges in incorporating IPE in the academic curriculum.


2021 ◽  
Author(s):  
Jesper Jørgensen ◽  
Panos Kefalas

Innovative reimbursement mechanisms have long been considered potential solutions to the data uncertainty associated with one-off, high-value gene therapies that have long-term therapeutic potential, combined with limited supporting evidence at launch. The launches of increasing numbers of such gene therapies in Europe and the USA in the past 5 years provide valuable exemplars of how innovative reimbursement mechanisms are used by healthcare system decision makers in practice. This review details the use of such reimbursement schemes for recently launched gene therapies in key European countries and the USA, and shows that they are more widespread in Europe than in the USA. Although innovative payment schemes are increasingly used across countries, differences in healthcare system structures (e.g., single- vs multi-payer systems) and willingness to pay mean that decision makers in different countries have different incentives to manage uncertainties around long-term, real-world product value.


Author(s):  
Prashant Mehta

India, one of the oldest civilizations and second most populous country is ethnically, linguistically, geographically, religious, and demographically diverse is poorly ranked due to complex public healthcare system, which suffers from insufficient funding, poor management. Poor health intertwined with poverty, affordability, accessibility, burden of infectious and non-communicable affecting lives of most Indians. Healthcare ecosystems are complex and still evolving, investments in service delivery system, infrastructure, and technology, are still being experimented and explored. India's booming population; increasing purchasing power; rising awareness of personal health and hygiene; and significant growth in infectious, chronic degenerative, and lifestyle diseases are driving the growing market. In this chapter we will explore accessible and affordable healthcare system, state of public healthcare, healthcare reforms, governance (Constitutional Provisions, Law, and Policy framework) in healthcare delivery, and Opportunity offered by market drivers.


2014 ◽  
Vol 3 (4) ◽  
pp. 55-65 ◽  
Author(s):  
Vassilis Fragoulakis ◽  
Elena Athanasiadi ◽  
Antonia Mourtzikou ◽  
Marilena Stamouli ◽  
Athanassios Vozikis

The aim of the present study is to provide an overview of recent reforms in Greece as imposed by the fiscal adjustments. Potential harmful consequences of these vast healthcare reforms are also discussed, as a collateral victim of the recession, in which case the real “patient” is the overall healthcare system. Based on an extended review of the related literature, the economic crisis, currently numbering five years in Greece, was accompanied by vast healthcare reforms and significant cuts in spending. In particular, austerity measures implemented, impose that health expenditure should not exceed 6% as a share of GDP. Savings were expected to be accomplished through vast changes, including the redetermination of both pharmaceutical reimbursement and pricing, reduction of public servants and cost containment regarding payments to the private sector. So far, there is a significant rise in demand for public hospital services, following a significant drop for private providers, including maternity hospitals, dental offices and surgery clinics. At the same time, elevated prevalence of certain diseases is already reported, although many researchers dispute over a causal association between recession and these health outcomes. Conclusively, it can be argued that the financial crisis is a no easy way out, and the Greek healthcare system is challenged as both resources and demand are rapidly changing. What is yet to answer is whether these reforms, along with a co-existing rise in demand of health services, could jeopardize the quality of the system.


2021 ◽  
pp. 479-519
Author(s):  
Ellen M. Immergut ◽  
Claus Wendt

This chapter provides an extended look at health politics and the compulsory health insurance system in Germany. It traces the historical development of the German healthcare system, characterized by its stability through a series of major regime shifts, including National Socialism, the post-World War II return to democracy, and the re-unification of Germany. Corporatist self-regulation has been a defining characteristic of the German system, but since 1989 elements of market and state-led governance have been enhanced, such as with the introduction of free choice of health insurance fund and elements of market competition among the funds, the pooling of insurance contributions into a central fund, and the introduction of substantial risk-sharing instruments. Despite the polarized left–right debate about introducing a universal citizens’ insurance versus a premium-based system, “grand coalition” politics have prevailed, with the broad contours of the German healthcare system being generally accepted and political competition focused on improving the already high quality of healthcare services.


2020 ◽  
Vol 36 (4) ◽  
pp. 304-310
Author(s):  
Wan Qing Wong ◽  
Liang Lin ◽  
Hong Ju ◽  
Kwong Ng

ObjectivesTo alert policy makers early about emerging health technologies that could significantly impact the healthcare system at the clinical, financial and organizational levels, the Agency for Care Effectiveness (ACE) in Singapore established a horizon scanning system (HSS) in 2019. This paper describes the development of the ACE HSS and showcases its application with cell and gene therapy products as the first example.MethodsA literature review of existing HSS methods, including the processes of the EuroScan International Network and other overseas horizon scanning agencies, was done to inform the development of our horizon scanning framework. The framework was first applied to the new and emerging cell and gene therapies.ResultsIdentification sources, filtration and prioritization criteria, and horizon scanning outputs for the HSS were developed in alignment to international best practices, with recommendations for technology uptake represented by a traffic light system. For the first horizon scanning exercise on cell and gene therapies, forty therapies passed the filtration step, of which eight were prioritized for further assessment. The few early reports developed were used to inform and prepare the healthcare system for their potential introduction, particularly in terms of the need to develop health and funding policies.ConclusionsEarly assessment of prioritized topics has provided support for strategic efforts within the Ministry of Health. Given that ACE's horizon scanning program is still in its infancy, the framework will continue to evolve to ensure relevance to our stakeholders so that it remains fit for purpose for our healthcare system.


Author(s):  
Prashant Mehta

India, one of the oldest civilizations and second most populous country is ethnically, linguistically, geographically, religious, and demographically diverse is poorly ranked due to complex public healthcare system, which suffers from insufficient funding, poor management. Poor health intertwined with poverty, affordability, accessibility, burden of infectious and non-communicable affecting lives of most Indians. Healthcare ecosystems are complex and still evolving, investments in service delivery system, infrastructure, and technology, are still being experimented and explored. India's booming population; increasing purchasing power; rising awareness of personal health and hygiene; and significant growth in infectious, chronic degenerative, and lifestyle diseases are driving the growing market. In this chapter we will explore accessible and affordable healthcare system, state of public healthcare, healthcare reforms, governance (Constitutional Provisions, Law, and Policy framework) in healthcare delivery, and Opportunity offered by market drivers.


Author(s):  
Vassilis Fragoulakis ◽  
Elena Athanasiadi ◽  
Antonia Mourtzikou ◽  
Marilena Stamouli ◽  
Athanassios Vozikis

The aim of the present study is to provide an overview of recent reforms in Greece as imposed by the fiscal adjustments. Potential harmful consequences of these vast healthcare reforms are also discussed, as a collateral victim of the recession, in which case the real “patient” is the overall healthcare system. Based on an extended review of the related literature, the economic crisis, currently numbering five years in Greece, was accompanied by vast healthcare reforms and significant cuts in spending. In particular, austerity measures implemented, impose that health expenditure should not exceed 6% as a share of GDP. Savings were expected to be accomplished through vast changes, including the redetermination of both pharmaceutical reimbursement and pricing, reduction of public servants and cost containment regarding payments to the private sector. So far, there is a significant rise in demand for public hospital services, following a significant drop for private providers, including maternity hospitals, dental offices and surgery clinics. At the same time, elevated prevalence of certain diseases is already reported, although many researchers dispute over a causal association between recession and these health outcomes. Conclusively, it can be argued that the financial crisis is a no easy way out, and the Greek healthcare system is challenged as both resources and demand are rapidly changing. What is yet to answer is whether these reforms, along with a co-existing rise in demand of health services, could jeopardize the quality of the system.


Sign in / Sign up

Export Citation Format

Share Document